{
  "url": "https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-2/paragraph-21",
  "json_url": "https://openlegislation.uk/veterinary-medicines-regulations-2013/schedule-2/paragraph-21.json",
  "legislation": "uksi/2013/2033",
  "legislation_title": "The Veterinary Medicines Regulations 2013",
  "legislation_url": "https://openlegislation.uk/veterinary-medicines-regulations-2013",
  "path": "schedule/2/paragraph/21",
  "kind": "paragraph",
  "number": "21",
  "heading": "Suspension, compulsory variation or revocation of authorisation",
  "text": "The Secretary of State may by notice suspend, vary or revoke an authorisation under paragraph 14 if the Secretary of State is satisfied that—\n(a) the holder of the authorisation no longer uses fit and proper processes;\n(b) the site at which the activity takes place is not suitable;\n(c) the equipment is not suitable;\n(d) the PRR has not carried out adequately the PRR’s responsibilities under these Regulations;\n(e) in the case of a person authorised under paragraph 14(1), that person has manufactured a veterinary medicinal product pursuant to that authorisation that is not within its scope;\n(f) the holder has not conducted an activity relating to the authorisation for five years or more;\n(g) the holder has not paid any fee required under these Regulations; or\n(h) the holder has not complied with any other provision in these Regulations.",
  "extent": "E+W+S",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Sch. 2 Pt. 2 (paras. 14-25 entitled \"Authorisation of autogenous vaccines, blood-banks, stem cell centres and products manufactured under the cascade\") substituted for Sch. 2 Pt. 2 (paras. 14-19 entitled \"Authorisation of manufacturers of autogenous vaccines\"), Pt. 3 (paras. 20-24 entitled \"Authorisation of blood banks\"), Pt. 4 (paras. 25-29 entitled \"Authorisation of manufacturers of products for administration under the cascade\") and Pt. 5 (paras. 30-35 entitled \"Authorisation of equine stem cell centres\") (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 92"
    },
    {
      "type": "E",
      "label": "E1",
      "text": "This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/2033/schedule/2/paragraph/21",
    "retrieved_at": "2026-10-29T00:44:44.019972+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}